Key result
Acute myocardial infarction is linked to ~23 days of lost life expectancy over three years.
Why the study?
Although mortality risk after acute myocardial infarction declines rapidly after the initial period, quantitative measures of residual risk during follow-up remain limited.
What is the restricted loss of life expectancy in patients with acute myocardial infarction compared to a matched general population cohort?
Cohort (n=27,705)
Yes
What is the restricted loss of life expectancy in patients with acute myocardial infarction compared to a matched general population cohort?
Answers are grounded in this paper and cite their sources.
Restricted loss of life expectancy provides an intuitive, patient-centered measure of residual risk after acute myocardial infarction, highlighting significant improvements in patient outcomes from 2012 to 2020.
Background The mortality risk of acute myocardial infarction declines rapidly after the initial period, yet the quantitative measures of residual risk in the follow‐up period remain limited. We aimed to assess restricted loss of life expectancy (LOLE) in patients with acute myocardial infarction. Methods We included patients from KAMIR (Korea Acute Myocardial Infarction Registry), a nationwide acute myocardial infarction registry, between 2012 and 2020. The survival of 27 705 patients (mean age, 64 years; 76% men) was compared with an age‐, sex‐, and calendar year–matched reference cohort derived from Korean population life tables. Three‐year restricted LOLE was estimated using a Royston–Parmar flexible parametric survival model adjusted for clinical characteristics. Results Overall, 3‐year restricted LOLE was 23 (95% CI, 22–25) days. In subgroup analyses, older age (≥75 years, 42 [95% CI, 37–47] days versus <50 years, 7 [95% CI, 3–10] days), female sex (44 [95% CI, 37–51] days versus male sex, 14 [95% CI, 11–17] days), and lower left ventricular ejection fraction (≤40%; 135 [95% CI, 128–142] days versus ≥50%, 0 [−2 to 1] days) were associated with higher 3‐year restricted LOLE. Across the study period, 3‐year restricted LOLE nearly halved from 36 (95% CI, 31–41) to 16 (95% CI, 9–23) days. Conclusions Restricted LOLE provides intuitive, patient‐centered measures of residual risk after acute myocardial infarction. It also demonstrated a significant improvements in patient outcomes over the study period.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2026) conducted a cohort in Acute myocardial infarction (n=27,705). Acute myocardial infarction vs. Age-, sex-, and calendar year-matched reference cohort was evaluated on 3-year restricted loss of life expectancy (LOLE) (23 days, 95% CI 22-25). Acute myocardial infarction was associated with an overall 3-year restricted loss of life expectancy of 23 days compared to a matched reference cohort.
Synapse has enriched 10 related papers. Consider them for comparative context: